Oncologists' perceptions of the usefulness of cancer survivorship care plan components.
Autor: | Haggstrom DA; Division of General Internal Medicine and Geriatrics, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA. dahaggst@iupui.edu.; Regenstrief Institute, Inc., Center for Health Services Research, 1101 West Tenth Street, Indianapolis, IN, 46202, USA. dahaggst@iupui.edu.; Center for Health Information and Communication, Department of Veterans Affairs, Veterans Health Administration, Health Services Research and Development Service, Indianapolis, IN, USA. dahaggst@iupui.edu., Kahn KL; David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.; RAND Corporation, Santa Monica, CA, USA., Klabunde CN; Office of Disease Prevention, Office of the Director, National Institutes of Health, Bethesda, MD, USA., Gray SW; City of Hope Comprehensive Cancer Center, Beckman Research Institute, Duarte, CA, USA., Keating NL; Department of Health Care Policy, Harvard Medical School, Boston, MA, USA.; Division of General Internal Medicine, Brigham and Women's Hospital, Boston, MA, USA. |
---|---|
Jazyk: | angličtina |
Zdroj: | Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2021 Feb; Vol. 29 (2), pp. 945-954. Date of Electronic Publication: 2020 Jun 14. |
DOI: | 10.1007/s00520-020-05531-9 |
Abstrakt: | Purpose: The Institute of Medicine recommends that cancer patients receive survivorship care plans (SCP) summarizing information important to the individual's long-term care. The various components of SCPs have varying levels of evidence supporting their impact. We surveyed medical oncologists to better understand how they perceived the relative value of different SCP components. Methods: Medical oncologists caring for patients in diverse US practice settings were surveyed (357 respondents; participation rate 52.9%) about their perceptions of the usefulness of various components of SCPs to both patients and primary care physicians (PCPs). Results: Oncologists perceived treatment summaries as "very useful" for PCPs but were less likely to perceive them as "very useful" for patients (55% vs. 40%, p < 0.001). Information about the psychological effects of cancer (41% vs. 29%; p < 0.001) and healthy behaviors (67% vs. 41%; p < 0.001) were considered more useful to patients than to PCPs. From 3 to 20% of oncologists believed that any given component of the SCP was not useful to either PCPs or patients. Oncologists who perceived SCPs to be more useful tended to be female or to practice in settings with a fully implemented electronic health record. Conclusions: Oncologists do not perceive all components of SCPs to be equally useful to both patients and PCPs. To be successfully implemented, the SCP should be efficiently tailored to the unique needs and knowledge of patients and their PCPs. A minority of oncologists appear to be late adopters, suggesting that some resistance to the adoption of SCPs remains. |
Databáze: | MEDLINE |
Externí odkaz: |